StopDown
Kapiva logo
News · 31 January 2026KapivaD2C ayurvedic supplements brandkapiva.in ↗

Kapiva builds science-backed ayurvedic brand

By · Editor ·

Founded 2016
  • Kapiva sells ayurvedic supplements for wellness, diabetes, heart health and gym nutrition
  • Founded in 2016, it raised nearly $120 Mn from investors including Fireside Ventures and OrbiMed
  • It focuses on clinical trials and R&D to attract younger consumers wary of heavy metals

What happened

  • Kapiva was launched as a D2C ayurvedic brand in 2016, with its first products rolled out in 2017.
  • It initially sold supplements for diabetes and heart ailments through contract manufacturing, later moving to own formulations.
  • The company opened ayurvedic clinics in Mumbai but shut them down by 2018 due to high costs and limited reach.
  • It pivoted to an online-first D2C model, selling through its own website, Amazon and Flipkart.
  • From 2019 to 2021, it hired a dedicated R&D head and built a team of 15-20 researchers.
  • It began clinical trials including in vitro and in vivo studies, and products now undergo up to 10 levels of testing.
  • In 2022, it raised a $28 Mn Series C from OrbiMed, which brought global healthcare expertise and DNA fingerprinting.
  • Last year, it raised a $60 Mn Series D from 360 One Asset and Vertex Ventures to bolster R&D, manufacturing and marketing.

Why it matters

  • India's ayurveda market is one-fourth of the $40 Bn pharma market, while China's traditional medicine market is a $50 Bn opportunity in an $80 Bn pharma market.
  • India's ayurveda lacks rigorous evidence-based scientific research, and heavy metals in ayurvedic drugs exceeding safe limits put off younger consumers.
  • Younger consumers prefer quick relief, while ayurveda demands time and patience.
  • India's D2C market is a $100 Bn opportunity with over 50,000 digital-first brands, and India has 427 Mn ecommerce users.

The business

  • Kapiva sells ayurvedic supplements across wellness, diabetes care, heart health and gym nutrition.
  • It sells through its own website, Amazon and Flipkart.
  • Products undergo up to 10 levels of testing, and clinical trials and certifications are mentioned on packaging.
  • Revenue in FY25 was INR 342 Cr, and it targets INR 600 Cr in the current fiscal.
  • Since FY23, revenues have nearly doubled every year, driven by repeat consumption.
  • Losses are narrowing to single digits.

The founders

Ameve Sharma

Founder
  • Carries the legacy of Baidyanath in his genes.
  • A management graduate from France.
  • Spent five years in the family business, then joined McKinsey as a consultant.
  • Spotted a dearth of modern science-backed ayurvedic brands.

Shrey Badhani

Co-founder
  • Former associate at Bain & Company with exposure to private equity and startups.

Who put in money

In numbers

INR 342 CrRevenue · FY25
INR 600 CrRevenue target · Current fiscal
nearly $120 MnTotal raised · As of 2026
INR 4.4 CrAngel round
$28 MnSeries C · 2022
$60 MnSeries D · Last year

What happens next

  • Bolster R&D, manufacturing and marketing with Series D funds.

Earlier rounds

  • Angel · INR 4.4 Cr
  • 2022 · Series C · $28 Mn · led by OrbiMed
  • Last year · Series D · $60 Mn · led by 360 One Asset and Vertex Ventures

Words to know

D2C
Direct-to-consumer, a business model where a brand sells its products directly to customers without intermediaries like wholesalers or retailers.
Ayurveda
An ancient Indian system of medicine that uses natural herbs and treatments to balance the body, mind and spirit.
Clinical trials
Scientific studies that test the safety and effectiveness of a product on humans or in labs before it is sold.
DNA fingerprinting
A technique used to identify the genetic makeup of plants or herbs to ensure their authenticity and purity in products.

The numbers around it

Healthcare & Life Sciences in January 2026: 12 rounds with a disclosed amount, $99.0 million in all; the biggest was Sukino ($31M). Every sector this year →

Read it as a card in the app

Everything on Kapiva → · All startup news on 31 January 2026 →

Is this Kapiva? Get your “Featured on StopDown” badge →